# Editorial: Potential therapeutic approaches of female hormones in the brain

**Authors:** Pelin Kelicen Ugur, Mariagiovanna Cantone

PMC · DOI: 10.3389/fphar.2025.1617394 · Frontiers in Pharmacology · 2025-05-27

## Full-text entities

- **Diseases:** gastric cancer (MESH:D013274), neuroinflammation (MESH:D000090862), neurodegenerative diseases (MESH:D019636), colorectal and liver cancer (MESH:D015179), cachexia (MESH:D002100), cognitive decline (MESH:D003072), breast cancer (MESH:D001943), endometrial carcinoma (MESH:D016889), ovarian cancer (MESH:D010051), cancer (MESH:D009369), PKU (MESH:D010661), -related diseases (MESH:D000077733), AD (MESH:D000544), stroke (MESH:D020521), atrial fibrillation (MESH:D001281), metastasis (MESH:D009362), depression (MESH:D003866), pain (MESH:D010146), mood disorders (MESH:D019964)
- **Chemicals:** mPRO (-), progesterone (MESH:D011374), E2 (MESH:D004958)
- **Species:** Homo sapiens (human, species) [taxon 9606], gut metagenome (species) [taxon 749906]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12150796/full.md

---
Source: https://tomesphere.com/paper/PMC12150796